中文 | English
Return
Total: 23 , 1/3
Show Home Prev Next End page: GO
Author:(Shengying LIU)

1.Downregulation of ubiquitous microRNA-320 in hepatocytes triggers RFX1-mediated FGF1 suppression to accelerate MASH progression.

Liu YANG ; Wenjun LI ; Yingfen CHEN ; Ru YA ; Shengying QIAN ; Li LIU ; Yawen HAO ; Qiuhong ZAI ; Peng XIAO ; Seonghwan HWANG ; Yong HE

Acta Pharmaceutica Sinica B 2025;15(8):4096-4114

2.Construction of an integrated early rehabilitation program for medical care and health based on the information-motivation-behavioral skills model and its application in patients undergoing total hip arthroplasty

Shengying WANG ; Mengjuan ZHANG ; Yuerong SUN ; Zhimei LIU ; Yufeng LI

Chinese Journal of Trauma 2025;41(4):406-413

3.Construction of an integrated early rehabilitation program for medical care and health based on the information-motivation-behavioral skills model and its application in patients undergoing total hip arthroplasty

Shengying WANG ; Mengjuan ZHANG ; Yuerong SUN ; Zhimei LIU ; Yufeng LI

Chinese Journal of Trauma 2025;41(4):406-413

4.Analyzing the influencing factors of depressive symptoms among medical staff in Beijing City

Li HU ; Dan LIU ; Shengying YAO ; Zihuan WANG ; Zhifeng SUN ; Liu LIU ; Yan YE

China Occupational Medicine 2024;51(6):665-670

5.Network Analysis-Based Identification of Core Symptoms in Different Chinese Medicine Syndromes During the Acute Phase of Ischemic Stroke

Lian GU ; Weitao WANG ; Dongmei LI ; Shengying LIU ; Xiaoxiao SONG ; Hong CAI ; Li SU

World Science and Technology-Modernization of Traditional Chinese Medicine 2024;26(11):2837-2845

6.Network Analysis-Based Identification of Core Symptoms in Different Chinese Medicine Syndromes During the Acute Phase of Ischemic Stroke

Lian GU ; Weitao WANG ; Dongmei LI ; Shengying LIU ; Xiaoxiao SONG ; Hong CAI ; Li SU

World Science and Technology-Modernization of Traditional Chinese Medicine 2024;26(11):2837-2845

7.Advances in poly(ethylene terephthalate) hydrolases.

Zhiyi ZHAO ; Guoqiang ZHANG ; Kun LIU ; Shengying LI

Chinese Journal of Biotechnology 2023;39(5):1998-2014

8.Establishment and application of evaluation criteria for clinical rational drug use of atosiban based on AHP-TOPSIS method

Jinjin YIN ; Peili DU ; Xiangping TAN ; Zhengrong MEI ; Shengying SHI ; Shaozhi LIU

China Pharmacy 2023;34(1):86-90

9.Study on the Quality Control Standard of Lvxintong Rugao

Binguo LIU ; Xiaoli WANG ; Shengying YE

Journal of Pharmaceutical Practice 2023;41(8):496-500

10.Feasibility of interim multipoint core needle biopsy pathological evaluation to predict effect of neoadjuvant therapy for breast cancer (with video)

Shikai HONG ; Shuhan WANG ; Zhengzhi ZHU ; Jianjun LIU ; Kuojun REN ; Shengying WANG

Chinese Journal of Endocrine Surgery 2023;17(5):524-529

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 23 , 1/3 Show Home Prev Next End page: GO